Neos Therapeutics Inc (NEOS) Return on Assets ROA from the third quarter of 2020 to third quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neos Therapeutics Inc   (NASDAQ: NEOS)


Neos Therapeutics Inc 's ROA from the third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Neos Therapeutics Inc 's ROA in the third quarter of 2020?
Neos Therapeutics Inc recorded a cumulative net loss of $-22 million during 12 months ending in the third quarter of 2020, resulting in a negative return on assets (ROA) of -28.5%.

However, within the Healthcare sector 416 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2020 from 3760 to 3843.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Total Assets Change -30.16 % -29.77 % -12.74 % -44.48 % 25.21 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -22 -19 -17 -17 -23
Return On Assets (TTM) -28.5 % -22.72 % -19.12 % -18.08 % -20.37 %
NEOS's Total Ranking # 3843 # 3760 # 3718 # 4210 # 3899
Total Assets (TTM) in million 64 63 89 91 92
Seq. Total Assets Change 2.22 % -29.64 % -1.96 % -0.96 % 2.8 %
Seq. Net Income Change - - - - -

NEOS's 5 Years Annual ROA >> Back to NEOS Management Effectiveness >> Compare NEOS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 154
Sector # 417
Overall # 3720

Return On Assets Statistics
High Average Low
-18.08 %
-49.78 %
-89.08 %
(Dec 31 2019)   (Mar 31 2017)





Financial Statements
Neos Therapeutics Inc 's Assets $ 64 million NEOS's Balance sheet
Neos Therapeutics Inc 's Income $ -5 million Quarterly NEOS's Income Statement
NEOS's Income by Division See NEOS's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change -18.39 % 3.73 % 33.95 % -34.51 % -
Total Assets in million 91 111 107 80 122
Y / Y Net Income Change - - - - -
Net Income in million -17 -52 -66 -83 -31
Annual Return On Assets -18.6 % -46.4 % -61.71 % -103.98 % -25.15 %

NEOS's 5 Years Annual ROA >> Back to NEOS Management Effectiveness >> Compare NEOS ROA to its Competitors



More Return On Assets Ratios
NEOS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NEOS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NEOS's Competitors
Subscribers only: Roa for Neos Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for NEOS's Customers

You may also want to know
NEOS's Roi NEOS's Inventory Turnover Ratio NEOS's Growth Rates NEOS's Dividend Comparisons
NEOS's Profitability Ratios NEOS's Asset Turnover Ratio NEOS's Dividend Growth
NEOS's Roe NEOS's Valuation Ratios NEOS's Financial Strength Ratios NEOS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.